Abstract: SA-PO1076
Saudi Central Board for Accreditation of Healthcare Institutions-Driven Quality Improvement Across the Diaverum Saudi Arabia Hemodialysis Network
Session Information
- Kidney Replacement Therapy and Care Delivery Innovations
October 24, 2026 | Location: Exhibit Hall A, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Dialysis
- 801 Dialysis: Hemodialysis and Frequent Dialysis
Authors
- Dammas, Hassnah, Diaverum Advanced for Medical Services, Riyadh, Saudi Arabia
- Galgo, Johanna S., Diaverum Advanced for Medical Services, Riyadh, Saudi Arabia
- Basubrain, Omar, Department of Medicine, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
- Fadlallah, Ayman Seddik, Diaverum Advanced for Medical Services, Riyadh, Saudi Arabia
- Albugami, Meteb M., Diaverum Advanced for Medical Services, Riyadh, Saudi Arabia
Background
The Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) sets Saudi Arabia's national healthcare quality framework. Diaverum Saudi Arabia operates a multi-site hemodialysis network where accreditation readiness requires standardized governance, risk mitigation, and clinical performance. We hypothesized that propagating findings from each surveyed clinic into network-wide corrective actions would accelerate readiness across all 18 clinics.
Methods
Multi-site pre-post QI project across 18 Diaverum hemodialysis clinics in Saudi Arabia, operational from May 2025. Staggered CBAHI surveys ran September 2025 to May 2026; all 18 were accredited. The intervention bundled gap analysis, staff training, mock surveys, risk register review, and network-wide corrective actions regardless of survey status. Pre/post: Q1 2025 vs Q2 2025-Q1 2026 (KPIs); 12-month symmetric windows (tickets); Jan-Apr vs May-Dec 2025 (incidents). KPI tracking was risk-stratified. Wilcoxon, Mann-Whitney U, and chi-square tests applied.
Results
Internal mock scores rose from 75% (baseline) to 89% mid-cycle (clinics not yet surveyed); all 18 reached a mean external CBAHI score of 97% (+22 pp). Above-tolerance risks were brought within tolerance (8/54 to 0/54). Across 3,833 maintenance tickets, 30-day closure rose 89.5% to 94.1% (p<0.001). Weekly treatment time achievement rose 73.2% to 81.4% (n=9, p=0.004), with shortened-treatment incidents falling 25% (n=8, p=0.016). AVF prevalence rose 79.1% to 80.1% (n=8, p=0.10), with a 27% drop in vascular access complications (n=7, p=0.094).
Conclusion
Network-wide propagation of corrective actions during CBAHI preparation was associated with accreditation scores rising 75% to 97% and concordant gains in risk, operational, clinical, and safety indicators. Secular trends cannot be excluded in a pre-post design, but this model may offer a scalable framework for multi-site dialysis accreditation.
Acknowledgment
We thank the leadership team for their sustained sponsorship and resourcing of this program, and the clinical, operational, and quality teams across the 18-clinic network, whose work made this program possible.